Does obesity increase C-Reactive Protein (CRP) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, obesity increases C-reactive protein (CRP) levels in the body. According to a study published in Circulation in 2004 1, obesity is associated with an increase in circulating inflammatory markers, including CRP and cytokines. Adipose tissue itself is a likely source of these excess cytokines, and interleukin-6 (IL-6) stimulates the production of CRP by the liver. The key points to consider are:

  • The increase in inflammatory markers is associated with insulin resistance and is an important predictor of atherosclerotic events
  • Weight reduction decreases plasma CRP concentration, with the decrease in CRP directly related to the amount of weight loss, fat mass, and change in waist circumference 1
  • Decreases in plasma IL-6, IL-18, P-selectin, and tumor necrosis factor concentrations have also been reported after weight loss in subjects who are obese 1 This highlights the importance of addressing excess weight to reduce systemic inflammation and improve overall health.

From the Research

Association between Obesity and CRP Levels

  • Obesity has been consistently associated with elevated levels of C-reactive protein (CRP), a marker of inflammation and predictor of cardiovascular risk 2, 3, 4, 5, 6.
  • Studies have shown that higher body mass index (BMI) is associated with higher CRP concentrations, even among young adults aged 17 to 39 years 2.
  • The association between obesity and CRP is stronger in women and North Americans/Europeans 3.
  • Visceral adipose tissue mass is also associated with increased CRP levels in patients with manifest vascular diseases 6.

Mechanisms underlying the Association

  • Human adipose tissue expresses and releases proinflammatory cytokines, such as interleukin 6, which can induce low-grade systemic inflammation in persons with excess body fat 2.
  • Adipose tissue inflammation is a major contributor to increased CRP in obesity, with subcutaneous adipose tissue (SAT) contributing more to the pro-inflammatory milieu than visceral adipose tissue (VAT) 4, 5.
  • The expression of pro-inflammatory genes is substantially higher in SAT than in VAT in individuals with morbid obesity 5.

Clinical Implications

  • Elevated CRP levels are present in 27.6% of the population, and clinically raised CRP levels are present in 6.7% of the population 2.
  • Obesity is associated with a state of low-grade systemic inflammation, which can increase the risk of cardiovascular disease and other metabolic complications 2, 3, 4, 5, 6.
  • Weight loss, such as that achieved through bariatric surgery, can lead to a decrease in CRP levels and a reduction in inflammation 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Obesity and C-reactive protein in various populations: a systematic review and meta-analysis.

Obesity reviews : an official journal of the International Association for the Study of Obesity, 2013

Research

High levels of CRP in morbid obesity: the central role of adipose tissue and lessons for clinical practice before and after bariatric surgery.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2015

Research

Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity.

Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.